Mode
Text Size
Log in / Sign up

Systematic Review of Schisandra chinensis for Metabolic Dysfunction-Associated Steatotic Liver Disease

Systematic Review of Schisandra chinensis for Metabolic Dysfunction-Associated Steatotic Liver…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider this preclinical evidence as hypothesis-generating; clinical efficacy and safety in MASLD are not established.

This is a systematic review of preclinical and pharmacological studies examining the effects of Schisandra chinensis Fructus (SCF) and its active metabolites (lignans, triterpenoids, volatile oils, organic acids) on metabolic dysfunction-associated steatotic liver disease (MASLD). The review synthesizes evidence from in vitro and animal models, focusing on hepatoprotective mechanisms.

Key findings indicate that SCF extract protects hepatocytes from damage, reduces hepatic fat accumulation, alleviates insulin resistance, and mitigates oxidative stress. These outcomes are reported qualitatively; no pooled effect sizes, p-values, or confidence intervals are provided. The review does not include human studies, and no safety data or adverse events are reported.

The authors acknowledge a limitation: systematic exploration of the integrated mechanisms involving these metabolites remains necessary. The review does not establish causality from primary studies, and no certainty assessment is presented.

For clinicians, this review highlights potential pharmacological activities of SCF in MASLD but does not support clinical use. The evidence is preclinical, and efficacy and safety in humans are unproven. Further research, including clinical trials, is needed before any practice recommendations can be made.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Schisandra chinensis Fructus (SCF) is a traditional Chinese herbal medicine with both medicinal and culinary uses. Its main active ingredients, including lignans, triterpenoids, volatile oils, and organic acids, have been utilized to treat liver diseases. SCF extract exhibits pharmacological activities such as protecting hepatocytes, reducing hepatic fat accumulation, alleviating insulin resistance, and mitigating oxidative stress, thus holding promising application prospects in alleviating metabolic dysfunction-associated steatotic liver disease (MASLD). The aim of our review is to summarize and organize recent literature regarding the active metabolites and pharmacology of SCF, so as to clarify the pharmacological mechanism of this herbal medicine and provide a reference for the research, development, and utilization of SCF, its compound preparations, and related health foods. Literature selection was performed using relevant databases in traditional Chinese medicine and biomedical sciences, based on the ethnopharmacological uses (medicinal and culinary) of SCF. Studies investigating the roles and mechanisms of SCF’s active metabolites in alleviating MASLD were primarily chosen. SCF contains multiple active metabolites, among which lignans, triterpenoids, volatile oils, and organic acids play crucial roles in alleviating MASLD. These metabolites exert pharmacological effects by protecting hepatocytes from damage, regulating hepatic lipid metabolism, improving insulin sensitivity, and resisting oxidative stress, collectively contributing to the mitigation of MASLD. However, systematic exploration of the integrated mechanisms involving these metabolites remains necessary. The active metabolites of SCF possess diverse pharmacological activities in alleviating MASLD. Clarifying their underlying mechanisms is beneficial for promoting further research, development, and application of SCF in medicine and health foods, providing a solid basis for related drug development and functional food utilization.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.